Clinical Trial Update: A Study to Test if Tenecteplase Helps People to Recover From an Acute Stroke When Given More Than 4.5 Hours After the Person Was Last Seen Well [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating whether administering tenecteplase more than 4.5 hours after last seen well improves recovery in acute ischemic stroke; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Tenecteplase (tenecteplase)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Acute Ischemic Stroke | Phase 3 | Status: RECRUITING